Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Collegium Pharmaceutical (COLL) over the last 9 years, with Q3 2025 value amounting to $2.85.

  • Collegium Pharmaceutical's Times Interest Earned rose 5059.57% to $2.85 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.83, marking a year-over-year decrease of 3313.24%. This contributed to the annual value of $2.3 for FY2024, which is 1463.96% up from last year.
  • Collegium Pharmaceutical's Times Interest Earned amounted to $2.85 in Q3 2025, which was up 5059.57% from $1.72 recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Times Interest Earned peaked at $3.7 during Q1 2021, and registered a low of -$7.17 during Q4 2021.
  • Over the past 5 years, Collegium Pharmaceutical's median Times Interest Earned value was $1.72 (recorded in 2025), while the average stood at $1.37.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Times Interest Earned crashed by 47008.25% in 2021, and later surged by 45990.51% in 2023.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Times Interest Earned stood at -$7.17 in 2021, then soared by 107.97% to $0.57 in 2022, then skyrocketed by 459.91% to $3.2 in 2023, then tumbled by 47.42% to $1.68 in 2024, then skyrocketed by 69.55% to $2.85 in 2025.
  • Its Times Interest Earned stands at $2.85 for Q3 2025, versus $1.72 for Q2 2025 and $1.04 for Q1 2025.